Mediderma, the professional division of the Valencian company Laboratories Sesderma, promotes its international expansion plan and announces its entry into the Chinese market through a strategic distribution agreement with Wanjing group, one of the main referents of the aesthetic medicine sector in China.
With this operation, Mediderma adds its presence worldwide, with sales in Latin America, the USA, Europe, the Middle East, Africa and Asia-Pacific. Mediderma thus implies in the Chinese market in order to maintain a more direct commercial relationship with its customers and enhance its growth. China is a market with a lot of cosmetic demand and key in the strategic growth plan of the Spanish group.
China, according to the Valencian company, is a key country in its international expansion strategy, which has promoted laboratories to create its own structure together with the human team necessary for it. In this way, Mediderma signs an agreement with Wanjing Group for two years, renewable, with the aim of directly controlling the entire value chain between the company and the Chinese consumer.
As Gabriel Serrano, president and founder of Laboratories Mediderma and Sesderma, China represents one of the areas with the greatest growth potential for the company. “Currently, China has 1.4 billion inhabitants, and Wanjing Group has a network of more than 45,000 professional aesthetic centers, which will allow Mediderma to significantly expand its presence in the Asian market,” said the company’s owner.
“It is a great opportunity to expand our presence and respond to the specific needs of Chinese skins, which require a unique approach in skin care products. With a solid strategy and effective products, we are sure that we can establish a trust relationship with Chinese customers and be a reference brand in the market,” they say from the company.
On the other hand, Sesderma is not new in the Asian giant market, since its products have been distributed there since 2017. In 2023, Sesderma was the only Spanish dermocosmetic company that appeared among the 30 most important in the elaborated ranking of the campaign of 11 of 11 of 11, according to the data provided by Timor, which is the main online sales platform in China and that moves more than 60% of the total digital trade in the Asian giant. In addition, the laboratory opened a subsidiary in China in 2019.
The business lines of the group founded by Dr. Gabriel Serrano are divided into the following: Sesderma, directly focused on the final consumer through pharmacies, parapharmacies and online sale; and Mediderma Professional Care, which manufactures, distributes and markets products and treatments for professional use, aimed exclusively at the aesthetic medical and dermatologist.
